Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Surgery,
Division of Cardiothoracic Surgery,
Department of Surgery, Division of Cardiothoracic Surgery
Marshall T. Bell has not added Biography.
If you are Marshall T. Bell and would like to personalize this page please email our Author Liaison for assistance.
Attenuation of spinal cord ischemia-reperfusion injury by specific α-2a receptor activation with dexmedetomidine.
Journal of vascular surgery Nov, 2012 | Pubmed ID: 22832266
Preservation of motor function after spinal cord ischemia and reperfusion injury through microglial inhibition.
The Annals of thoracic surgery May, 2013 | Pubmed ID: 23541432
Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia.
Journal of vascular surgery Jul, 2013 | Pubmed ID: 23850057
Toll-like receptor 4-dependent microglial activation mediates spinal cord ischemia-reperfusion injury.
Circulation Sep, 2013 | Pubmed ID: 24030400
Dexmedetomidine, an α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion.
The Journal of thoracic and cardiovascular surgery Jan, 2014 | Pubmed ID: 24035379
University of Colorado
Marshall T. Bell1,
T. Brett Reece1,
Phillip D. Smith1,
Joshua Mares1,
Michael J. Weyant1,
Joseph C. Cleveland Jr.1,
Kirsten A. Freeman1,
David A. Fullerton1,
Ferenc Puskas2
1Department of Surgery, Division of Cardiothoracic Surgery, University of Colorado,
2Department of Anesthesiology, University of Colorado
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.